Compass Therapeutics to Participate in Upcoming Investor Events

Company Overview - Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases [2] - The company was founded in 2014 and is headquartered in Boston, Massachusetts [2] - Compass's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth [2] Product Pipeline - The company is developing a pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective antitumor response [2] - Key strategies include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance [2] - Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data [2] Upcoming Investor Events - Compass Therapeutics will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 11:00am ET in New York, NY [1] - The company will also attend the Cantor Global Healthcare Conference on September 17, 2024, at 8:35am ET, also in New York, NY [1] - Presentations from these events will be archived for 90 days on Compass's Events page [1]